Free Trial

Chemed Co. (NYSE:CHE) Shares Sold by TD Asset Management Inc.

Chemed logo with Medical background
Remove Ads

TD Asset Management Inc. trimmed its stake in shares of Chemed Co. (NYSE:CHE - Free Report) by 7.2% in the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 271,621 shares of the company's stock after selling 21,039 shares during the period. TD Asset Management Inc. owned approximately 1.80% of Chemed worth $143,905,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in the stock. Raymond James Financial Inc. purchased a new stake in shares of Chemed in the fourth quarter worth about $42,023,000. HighTower Advisors LLC lifted its stake in shares of Chemed by 78.0% in the 3rd quarter. HighTower Advisors LLC now owns 3,730 shares of the company's stock valued at $2,246,000 after purchasing an additional 1,634 shares during the last quarter. XTX Topco Ltd boosted its holdings in shares of Chemed by 111.5% in the 3rd quarter. XTX Topco Ltd now owns 2,843 shares of the company's stock worth $1,709,000 after purchasing an additional 1,499 shares during the period. Geode Capital Management LLC increased its position in shares of Chemed by 4.9% during the 3rd quarter. Geode Capital Management LLC now owns 335,443 shares of the company's stock valued at $201,820,000 after purchasing an additional 15,791 shares during the last quarter. Finally, Signal Advisors Wealth LLC raised its holdings in Chemed by 60.7% during the 4th quarter. Signal Advisors Wealth LLC now owns 4,995 shares of the company's stock valued at $2,647,000 after buying an additional 1,886 shares during the period. Institutional investors own 95.85% of the company's stock.

Remove Ads

Insider Buying and Selling at Chemed

In other Chemed news, CEO Kevin J. Mcnamara sold 2,000 shares of the company's stock in a transaction dated Thursday, March 6th. The shares were sold at an average price of $593.67, for a total value of $1,187,340.00. Following the completion of the transaction, the chief executive officer now owns 102,679 shares in the company, valued at approximately $60,957,441.93. This represents a 1.91 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Also, VP Brian C. Judkins purchased 145 shares of the business's stock in a transaction that occurred on Monday, December 30th. The stock was acquired at an average price of $519.50 per share, with a total value of $75,327.50. Following the purchase, the vice president now owns 1,678 shares in the company, valued at $871,721. This represents a 9.46 % increase in their ownership of the stock. The disclosure for this purchase can be found here. 3.32% of the stock is currently owned by corporate insiders.

Analyst Ratings Changes

A number of analysts recently weighed in on CHE shares. Royal Bank of Canada increased their price objective on shares of Chemed from $633.00 to $667.00 and gave the stock an "outperform" rating in a research report on Friday, March 14th. StockNews.com raised shares of Chemed from a "hold" rating to a "buy" rating in a research note on Friday, March 7th.

Get Our Latest Stock Report on CHE

Chemed Stock Performance

Shares of Chemed stock traded down $6.42 during trading on Friday, hitting $605.94. 162,388 shares of the company's stock were exchanged, compared to its average volume of 93,565. The stock has a market capitalization of $8.87 billion, a price-to-earnings ratio of 30.62, a PEG ratio of 2.15 and a beta of 0.43. The business has a 50-day simple moving average of $574.16 and a 200-day simple moving average of $566.66. Chemed Co. has a 52-week low of $512.12 and a 52-week high of $642.68.

Chemed Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Friday, March 14th. Investors of record on Monday, February 24th were given a dividend of $0.50 per share. This represents a $2.00 annualized dividend and a yield of 0.33%. The ex-dividend date of this dividend was Monday, February 24th. Chemed's dividend payout ratio is currently 10.05%.

Chemed Profile

(Free Report)

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.

Read More

Institutional Ownership by Quarter for Chemed (NYSE:CHE)

Should You Invest $1,000 in Chemed Right Now?

Before you consider Chemed, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Chemed wasn't on the list.

While Chemed currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Energy Stocks to Buy and Hold Forever Cover

With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.

Get This Free Report
Like this article? Share it with a colleague.
Remove Ads

Featured Articles and Offers

3 Quantum Computing Stocks to Watch in 2025 (That Aren't Rigetti)

3 Quantum Computing Stocks to Watch in 2025 (That Aren't Rigetti)

Investors are buying the dip on quantum computing stocks, but is now the right time to get in? MarketBeat analyst Chris Markoch breaks down three intriguing picks beyond Rigetti.

Related Videos

Investing in Quantum Computing: Is Rigetti the Stock to Watch?

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines

Remove Ads